Recent 12% Price Drop of Elanco Animal Health (NYSE:ELAN)’s stock price may have disappointed insiders who bought US$1.3 million worth of shares at an average price of US$26.73 over the past 12 months. This is not good because insiders invest based on the expectation that the money will appreciate over time. However, as a result of recent losses, the initial investment is now only US$746,000.
While I would never suggest that investors should base their decisions solely on what the company’s directors have done, we believe it is foolish to completely ignore insider trading.
If you are not interested in investigating ELAN insider trading, freedom A list of interesting investment ideas that may inspire your next investment!
Elanco Animal Health insider trading in the past year
It turns out that last year’s largest insider takeover was the $294,000 worth of shares by the independent chairman of the board of directors, Roy Hoover, at about $29.38 per share. This means the insider wanted to buy the stock even though the stock was higher than his US$15.38 (recent price). Their views may have changed since then, but at least it shows they were optimistic at the time. For us, it is very important to consider the price an insider pays for a stock. If they paid more than the current price, it’s generally more encouraging because it suggests they found value at a higher level as well.
Over the past 12 months, Elanco Animal Health insiders have bought, but not sold, shares. The chart below shows insider trading (by company and individual) over the past year. Clicking on the chart will show you all individual deals, such as stock, individual, and date.
Elanco Animal Health isn’t the only stock that insiders are buying.Let’s take a look at this freedom List of companies growing with insider buying.
Another way to test the alignment of company leaders with other shareholders is to look at the number of shares they own. If an insider owns a sizeable amount of stock in a company, I think that’s a good sign. An Elanco Animal Health insider appears to own his 0.3% of the company, worth about $23 million. Certainly we’ve seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest coordination between insiders and other shareholders.
What does this data tell you about the Elanco Animal Health Insider?
The fact that there has been no Elanco Animal Health insider trading lately certainly doesn’t bother us. But insiders have shown more appetite for stocks this past year. Insiders own shares in Elanco Animal Health and I see no evidence that they are worried about the future.So you definitely have to watch this freedom Report showing analyst forecasts for Elanco Animal Health.
of course Elanco Animal Health may not be the best stock to buySo you might want to watch this freedom A collection of quality companies.
For the purposes of this article, an insider is an individual who reports a transaction to the relevant regulatory body. Currently, we consider open market transactions and private disposals, but not derivative transactions.
Do you have feedback on this article? What interests you? contact directly with us. Or send an email to our editorial team (at) Simplywallst.com.
This article by Simply Wall St is general in nature. We provide comments based on historical data and analyst projections using only unbiased methodologies and our articles are not intended as financial advice. It is not a recommendation to buy or sell stocks and does not take into account your objectives or financial situation. We aim to deliver long-term focused analysis based on fundamental data. Please note that our analysis may not take into account the latest price-sensitive company announcements or qualitative materials. Is not …
Discounted cash flow calculation for all stocks
Wall St simply does a detailed discounted cash flow calculation every 6 hours for every stock on the market. here. It’s free.